当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第7期
编号:12876724
血栓抽吸联合替罗非班及硝普钠对急性心肌梗死患者无复流的影响(4)
http://www.100md.com 2016年3月5日 《中国现代医生》 2016年第7期
     [11] Liu CP,Lin MS,Chiu YW,et al. Additive benefit of glycoprotein IIb/IIIa inhibition and adjunctive thrombus aspiration during primary coronary intervention:Results of the initial thrombosuction and tirofiban infusion(ITTI) trial[J]. Int J Cardiol,2012,156(2):174-179.

    [12] Zhou SS,Tian F,Chen YD,et al. Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction[J]. J Geriatr Cardiol,2015,12(2):135-142.

    [13] Jolly SS,Cairns J,Yusuf S,et al. Design and rationale of the TOTAL trial:A randomized trial of routine aspiration Thrombectomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI[J]. Am Heart J,2014,167(3):315-321.

    [14] Mahmood MM,Watt J,Ahmed JM. Thrombus aspiration during primary percutaneous coronary intervention for acute myocardial infarction:A review of clinical evidence and guidelines[J]. World J Cardiol,2015,7(12):889-894.

    (收稿日期:2015-12-28), http://www.100md.com(毛幼林 黄琼 王瑞敏)
上一页1 2 3 4